TECH NEWS: Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+ (Keerthi Vedantam/Crunchbase News)

Saturday, 22 October 2022

Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+ (Keerthi Vedantam/Crunchbase News)

via Techmeme https://ift.tt/31ymDtS

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)